Bailey J W, Haymond M W, Miles J M
Department of Medicine, Mayo Clinic, Rochester, Minnesota 55905.
Am J Physiol. 1990 May;258(5 Pt 1):E850-5. doi: 10.1152/ajpendo.1990.258.5.E850.
Previous studies have indicated that simultaneous infusions of two ketone body tracers ([13C]acetoacetate and [14C]beta-hydroxybutyrate) provide accurate estimates of exogenous ketone body inflow when an open two-pool model is employed. In the present studies, net hepatic ketone body production was determined from surgically placed arterial, portal venous, and hepatic venous catheters in conscious diabetic (n = 6) and 4-day fasted (n = 7) dogs. [13C]acetoacetate and [14C]beta-hydroxybutyrate were infused simultaneously, and ketone body production was calculated from either acetoacetate (AcAc) single-isotope data, beta-hydroxybutyrate (beta-OHB) single-isotope data, the sum of individual fluxes, or the two-pool model. In fasted animals, both the AcAc single-isotope calculation and the sum of individual fluxes overestimated net hepatic production by approximately 50% (P less than 0.05), whereas the beta-OHB single-isotope calculation and the two-pool model gave accurate estimates. In the diabetic animals, the beta-OHB single-isotope calculation underestimated net hepatic production by approximately 30% (P less than 0.05). The sum of individual fluxes overestimated net hepatic production by approximately 46% (P less than 0.05), whereas both the AcAc single-isotope calculation and the two-pool model gave accurate estimates. In conclusion, single-isotope methods give erroneous estimates of net hepatic production of ketone bodies. In contrast, a two-pool model provided an accurate estimate of net hepatic production and thus appears to be suitable for determination of ketone body kinetics in humans.
先前的研究表明,当采用开放的双池模型时,同时输注两种酮体示踪剂([13C]乙酰乙酸和[14C]β-羟基丁酸)可对外源性酮体流入量进行准确估算。在本研究中,通过在清醒的糖尿病犬(n = 6)和禁食4天的犬(n = 7)身上手术放置动脉、门静脉和肝静脉导管来测定肝脏酮体的净生成量。同时输注[13C]乙酰乙酸和[14C]β-羟基丁酸,并根据乙酰乙酸(AcAc)单同位素数据、β-羟基丁酸(β-OHB)单同位素数据、各通量之和或双池模型来计算酮体生成量。在禁食动物中,AcAc单同位素计算和各通量之和均高估肝脏净生成量约50%(P < 0.05),而β-OHB单同位素计算和双池模型给出了准确估算值。在糖尿病动物中,β-OHB单同位素计算低估肝脏净生成量约30%(P < 0.05)。各通量之和高估肝脏净生成量约46%(P < 0.05),而AcAc单同位素计算和双池模型均给出了准确估算值。总之,单同位素方法对肝脏酮体净生成量的估算存在误差。相比之下,双池模型能准确估算肝脏净生成量,因此似乎适用于测定人体酮体动力学。